https://www.selleckchem.com/pr....oducts/crenolanib-cp
6%, P  less then  .01). No significant difference was found in any background factors between the 2 groups. Twenty-five patients (34.7%) experienced recurrence after pulmonary metastasectomy. The most common site of recurrence was the lung (48%). Among the 12 cases of recurrence of pulmonary metastasis, 11 cases belonged to the less then 9 months group. A multivariable survival analysis found that the interval period of less then 9 months was a significant predictor of recurrence.Our study suggests that clinical follow-up f